logo
Plus   Neg
Share
Email

Stock Alert: Tenable Holdings Hits New High Following Q2 Results, Outlook

Shares of cyber security solutions provider Tenable Holdings, Inc. (TENB) are up more than 14% Wednesday morning following beter-than-expected second-quarter results. The company also provided third-quarter as well as full-year outlook, exceeding analysts' view.

The stock touched a new high of $35.01 this morning.

Second-quarter earnings per share of $0.04, beat the average estimate of analysts polled by Thomson Reuters of $0.05 loss per share and compared to a loss per share of $0.10 in the second quarter of 2019.

Revenue for the quarter was $107.2 million, up 26% year-over-year.

For the third-quarter, Tenable expects revenue in the range of $108.0 million to $110.0 million and adjusted earnings per share in the range of $0.02 to $0.03. Analysts expect loss of $0.05 per share on revenue of $108.74 million for the quarter.

For the full-year ending December 31, 2020, the company sees revenue in the range of $428.0 million to $433.0 million and adjusted earnings per share in the range of $0.00 to $0.03. The consensus estimate for earnings is $0.25 loss per share on revenue of $427.48 million.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Las Vegas, Nevada-based Mr. Wok Foods has recalled about 200,000 pounds of meat and poultry products for misbranding and undeclared allergens, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS said. The recalled products may contain known allergens such as milk, wheat, soy, peanuts, or oysters. They may also contain MSG, sesame products, or sulfites. The U.S. Food and Drug Administration approved the first oral drug to treat patients two months of age and older with spinal muscular atrophy (SMA) that can be taken at home. Roche subsidiary Genentech's Evrysdi (risdiplam) is also the second FDA-approved drug to treat this rare and often fatal genetic disease affecting muscle strength and movement. Supermarket chain Wegmans Food Markets, Inc. is recalling select Valencia oranges, lemons, and various other products containing fresh lemon citing potential contamination with Listeria monocytogenes, the U.S. Food and Drug Administration announced. The recall was initiated after Wegmans' lemons and oranges supplier Freshouse Produce LLC, issued a recall of its supplies.
RELATED NEWS
Follow RTT